Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open-label Study of the Effects of Elagolix in Adult Premenopausal Females

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01403038
Recruitment Status : Completed
First Posted : July 27, 2011
Last Update Posted : January 8, 2013
Sponsor:
Collaborator:
Neurocrine Biosciences
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2012
Actual Study Completion Date : November 2012